Drug intelligence / Profile preview

rehmannia glutinosa oligosaccharide

Development stage
Preclinical
Modality
Microbiome-Derived Products → Microbiome Therapeutics
Administration
Intraperitoneal, Oral
01

Overview

Rehmannia glutinosa oligosaccharide (RGO) is a natural oligosaccharide derived from the traditional Chinese medicine herb *Rehmannia glutinosa*. It is prepared through water extraction, decolorization, impurity removal, purification, and drying. RGO has demonstrated protective effects against lipopolysaccharide (LPS)-induced intestinal inflammation and barrier injury, showing anti-inflammatory and antioxidant properties. It also exhibits hypoglycemic effects in hyperglycemic and diabetic models and promotes the differentiation of bone marrow mesenchymal stem cells into cardiomyocyte-like cells. Furthermore, RGO can enhance the viability and proliferative capacity of human adipose-derived mesenchymal stem cells and alleviate H2O2-induced apoptosis, potentially by upregulating Vascular endothelial growth factor (VEGF) and Hepatocyte growth factor (HGF). Its mechanisms involve modulating gut microbiota composition, enhancing intestinal barrier-related proteins, and influencing various inflammatory and antioxidant markers.

Other names
RGOROS生地低聚糖
02

Targets

NeuraminidaseGPX4 (Glutathione peroxidase 4)G6PC1 (Glucose 6-phosphatase alpha)HGF (Hepatocyte growth factor)IL1B (Interleukin-1 beta)IL-17A (Interleukin-17A)IL-6 (Interleukin 6)OCLN (Occludin)Misfolded SOD1TNFA (Tumor necrosis factor alpha (soluble))VEGFA (Vascular endothelial growth factor A)TJP1 (Tight junction protein 1 (ZO-1))

Beyond the preview

Go deeper on rehmannia glutinosa oligosaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rehmannia glutinosa oligosaccharide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call